2,985 hedge funds and large institutions have $100B invested in Pfizer in 2024 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 933 increasing their positions, 1,460 reducing their positions, and 245 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

8% less capital invested

Capital invested by funds: $109B → $100B (-$8.71B)

15% less call options, than puts

Call options by funds: $3.28B | Put options by funds: $3.87B

36% less repeat investments, than reductions

Existing positions increased: 933 | Existing positions reduced: 1,460

Holders
2,985
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
42
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.28B
Puts
$3.87B
Net Calls
Net Calls Change

Top Sellers

1 -$644M
2 -$337M
3 -$293M
4
JP Morgan Chase
JP Morgan Chase
New York
-$285M
5
Barclays
Barclays
United Kingdom
-$277M
Name Holding Trade Value Shares
Change
Change in
Stake
2476
$250K
2477
$249K
2478
$249K
2479
$248K
2480
$248K
2481
$248K
2482
$248K
2483
$248K
2484
$247K
2485
$247K
2486
$247K
2487
$247K
2488
$247K
2489
$247K
2490
$246K
2491
$245K
2492
$245K
2493
$245K
2494
$244K
2495
$244K
2496
$244K
2497
$244K
2498
$244K
2499
$243K
2500
$243K